Where does Tolero Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tolero Pharmaceuticals, Inc. ranks #15,009 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tolero Pharmaceuticals, Inc. hold?

Tolero Pharmaceuticals, Inc. holds 20 US utility patents granted between 2016 and 2020, spanning 8 technology areas.

What is Tolero Pharmaceuticals, Inc.'s Innovation Score?

Tolero Pharmaceuticals, Inc. has an Innovation Score of 31.8 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tolero Pharmaceuticals, Inc. focus on?

Tolero Pharmaceuticals, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 20 patents, ranking #980 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Tolero Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Tolero Pharmaceuticals, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Tolero Pharmaceuticals, Inc.'s patents?

Tolero Pharmaceuticals, Inc.'s patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tolero Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tolero Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 20 granted patents across 8 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tolero ranks #15,009 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 8 technology areas.

#15,009
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.8/100): 18.9
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15009 · US Corporation #15,009 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #15,009/49,997
PHOTO-FINISH THE Sy-klone
CPC-NARROW A61P · 8 areas
INNOV-THIN 31.8/100
CLAIMS-RICH 18.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: THE Sy-klone Company, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tolero’s 31.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (33%) Velocity 0.0 pts (0%) Breadth 10.0 pts (31%) Claim depth 11.3 pts (36%)

Qualcomm Incorporated · highest

85
Tolero Pharmaceuticals · this assignee

32
3D Lighting… · lowest

7

What this shows Tolero's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tolero?

Each dot is one of Tolero’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tolero’s own 18.9 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tolero vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tolero's grants concentrate

Tolero Pharmaceuticals, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2017. By volume, Tolero sits between THE Sy-klone Company, LLC and Tsmc Solar Ltd..

THE Sy-klone

20
Thyssenkrupp Roth…

20
Tokai University…

20
Tokyo GAS

20
Toyota Motor Sale…

20
Trojan

20
Trumpf Huettinger…

20
Tsmc Solar

20
Tolero Pharmaceut… ◀

20

What this shows Tolero holds 20 patents at rank #14,985, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tolero

By rank, the assignees closest to #14,985 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Tolero's primary technology class.

Tolero's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Tolero Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	15.0%
2017	2	10.0%
2018	3	15.0%
2019	8	40.0%
2020	4	20.0%

Which technologies does Tolero Pharmaceuticals, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

C07D - Heterocyclic Compounds 14

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 6

C07K - Peptides 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tolero Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Tolero Pharmaceuticals, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #15,009 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tolero Pharmaceuticals, Inc. against THE Sy-klone Company, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.